DUBLIN , June 2, 2022 /PRNewswire/ -- The "Global Meat Analogs Protein Ingredients Growth Opportunities" report has been added to ResearchAndMarkets.com's offering.
This report assesses the opportunity across the global meat analogs protein ingredients market from 2017 to 2026. Among the different plant protein ingredients, soy protein accounted for the highest share in 2020.
However, rising demand for clean-label, non-GMO, non-allergenic protein ingredients will drive demand for soy and wheat protein alternatives such as pea protein. Chickpea and fava beans are also seeing increased uptake in the meat analogs space.
Meat alternatives or meat analogs are defined as products obtained through alternative protein ingredients such as plant protein or microbial protein; they can mimic the taste, texture, and cooking qualities of animal-derived meat products. The growing number of flexitarians will continue to be a key driver of global meat analog industry growth. Millennials will also drive the shift to healthy and sustainable diets. Other factors expected to fuel adoption include the rising environmental and health concerns among consumers. As consumers gain awareness of the environmental impact of animal-derived food products, demand for sustainable alternative protein sources will rise. The use of sustainable production technologies (fermentation techniques to produce single-cell proteins (SCPs) such as mycoprotein, which can be used to produce meat alternatives) is also gaining momentum. As sustainability becomes an important determinant for new-generation consumers, opportunities for microbial or cell-cultured proteins will expand. Fungal and algae are the key types of microbial proteins being explored. Among the fungal proteins, mycoprotein is expected to witness strong growth over the forecast period, with some of the major companies projected to offer the ingredient on a much larger scale over the next 2-5 years.
Microalgae whole biomass protein is another alternative that holds significant growth opportunity, provided companies can overcome the color and the flavor challenges associated with its use in meat analogs. Spirulina and chlorella are the key microalgae species being used; however, the industry is also exploring other micro and macroalgae species for application in meat and seafood analogs. Geographically, North America and Europe accounted for a combined high share (they drove the bulk of the ingredient demand). However, Asia-Pacific is expected to become the hotspot of the plant-based meat revolution over the next 5-10 years. China , Singapore , Southeast Asian countries, and Australia and New Zealand will drive most of the ingredient demand. Latin America and the Middle East are also expected to witness strong penetration of plant-based meat analogs during the forecast period, fuelling protein ingredient growth in these regions. In terms of competitive environment, the plant protein ingredient category is dominated by global and regional manufacturers (Chinese companies hold a significant share in the soy protein ingredient space). Value chain consolidation is a prevalent trend as companies are looking to move up the supply chain through organic and inorganic growth strategies.
Start-ups also want to offer microbial protein for meat analog applications; however, only a few well-established brands exist, including Quorn Foods, Corbion, and Duplaco. Partnerships between microbial protein manufacturers and product formulators such as Nestle and Unilever are testament to the high growth opportunity in this space.
Key Topics Covered: 1. Strategic Imperatives
Why Is It Increasingly Difficult to Grow?
The Impact of the Top Three Strategic Imperatives on the Meat Analogs Protein Ingredients Market
Growth Opportunities Fuel the Growth Pipeline Engine
2. Growth Opportunity Analysis, Meat Analogs Protein Ingredients Market
Key Questions this Study will Answer
Revenue Forecast by Product Type
Unit Shipment Forecast by Product Type
Revenue and Unit Shipment Forecast Analysis by Product Type
Unit Shipment Forecast by Region
Revenue and Unit Shipment Forecast Analysis by Region
The Impact of the COVID-19 Pandemic on the Meat Analogs Industry
The Impact of the COVID-19 Pandemic on the Meat Analogs Protein Ingredients Market
Pricing Trends and Forecast Analysis
Competitive Landscape - Product Mapping (Plant Proteins)
Competitive Landscape - Product Mapping (Microbial Proteins)
3. Growth Opportunity Analysis, Plant Protein Market
Plant-based Meat Analogs - Overview
Revenue Forecast by Product Type
Unit Shipment Forecast by Product Type
Revenue and Unit Shipment Forecast Analysis by Product Type, Plant Protein Market
Revenue Forecast by Region, Plant Protein Market
Unit Shipment Forecast by Region, Plant Protein Market
Revenue and Unit Shipment Forecast Analysis by Region, Plant Protein Market
Product Launches by Key Manufacturers, Plant Protein Market
Market Activities of Key Manufacturers, Plant Protein Market
Patent Analysis of Key Manufacturers, Plant Protein Market
4. Growth Opportunity Analysis, Microbial Protein Market
Revenue Forecast by Product Type
Unit Shipment Forecast by Product Type
Revenue and Unit Shipment Forecast Analysis by Product Type
Revenue Forecast by Region, Microbial Protein Market
Unit Shipment Forecast by Region, Microbial Protein Market
Revenue Forecast by Region, Fungal Protein Market
Unit Shipment Forecast by Region, Fungal Protein Market
Revenue Forecast by Region, Algae Protein Market
Unit Shipment Forecast by Region, Algae Protein Market
Revenue and Unit Shipment Forecast Analysis by Region, Microbial Protein Market
Market Activities of Key Manufacturers, Microbial Protein Market
Patent Analysis of Key Assignees, Microbial Protein Market
5. Growth Opportunity Analysis, Cell-cultured Protein
Regulatory Scenario and Government Policies, Cell-cultured Protein
Opportunity Forecast Analysis, Cell-cultured Protein
Key Market Activities, Cell-cultured Protein
6. Growth Opportunity Universe, Meat Analogs Protein Ingredients Market
Growth Opportunity 1 - Portfolio Expansion Offers Novel Protein Ingredients and Caters to Changing Consumer Demand for Clean-Label and Sustainable Alternatives, 2026
Growth Opportunity 2 - Strategic Partnerships across the Meat Analog Supply Chain to Accelerate Plant-based Product Offerings, 2026
Growth Opportunity 3 - Technological Developments Help Protein Ingredients Mimic the Texture of Meat Products and Remain the Key to Higher Penetration, 2026
For more information about this report visit https://www.researchandmarkets.com/r/8y2h0k
Research and Markets Laura Wood , Senior Manager press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
View original content:https://www.prnewswire.com/news-releases/global-meat-analogs-protein-ingredients-market-analysisopportunity-report-2021-animal-welfare-sustainability-and-health-concerns-amidst-a-global-pandemic-fuel-investment-and-innovations-301560043.html
Bridgewater’s co–chief investment officer said the U.S. economy could slow down further.
The rate of U.S. inflation reached a 40-year high of 8.6% in May as overall prices for things including rent, gas and food all remain on the rise. “I personally believe that this inflation is here to stay for quite some time,” Orman recently told CNBC, prior to the release of May’s CPI data from the U.S. Bureau of Labor Statistics. The first is a fixed rate when the purchaser buys the bond, and the second is the inflation adjustment rate, which is reset every six months based on inflation.
The U.S. hasn't yet entered a recession -- which is officially defined as two consecutive quarters of negative GDP growth -- but runaway inflation, stagnant wages, food shortages, rising interest rates, and geopolitical turmoil could all break this fragile economy's back in the near future. If that happens, growth stocks will fall further as value stocks become even more attractive. Altria is the top tobacco company in America.
Yahoo Finance Live’s Brian Sozzi, Brad Smith, and Julie Hyman discuss quarterly earnings for DocuSign.
(Bloomberg) -- Former Treasury Secretary Lawrence Summers said the Federal Reserve has failed to account for its mistakes and to realize the damage to its credibility after the latest inflation data dashed hopes that a peak had been reached.Most Read from BloombergUS Lifts Covid-19 Test Requirement for International TravelUS Inflation Quickens to 40-Year High, Pressuring Fed and BidenEating Two Portions of Fish Per Week Linked to Deadly Skin CancerFive Key Moments From the Jan. 6 Capitol Riot He
Yahoo Finance's Brian Cheung and Jared Blikre join the Live show to break down the market sell-off resulting from today's CPI data, the impact of inflation on energy commodities, and the bond market.
LOS ANGELES (Reuters) -U.S. President Joe Biden on Friday accused the U.S. oil industry, and ExxonMobil in particular, of capitalizing on a supply shortage to fatten profits. U.S. consumer inflation accelerated in May as gasoline prices hit a record high and the cost of food soared, leading to the largest annual increase in four decades. Biden, who came into office vowing to reduce U.S. dependence on fossil fuels, said on Friday he was hoping to speed up oil production, which is expected to hit record highs in the United States next year.
In this article, we discuss 10 beaten-down Asian stocks to buy today. If you want to see more stocks in this selection, click 5 Beaten-Down Asian Stocks to Buy Today. While the US dollar remains strong, Asian markets on June 10 stumbled on the back of higher rates guidance from the European Central Bank and […]
What to do in today’s market? The last few trading sessions of declining stocks would seem to indicate that the late-May rally we saw has run its course. But that doesn’t mean the opportunities for buy-minded investors are all gone. The recent declines, and the overall downward trend we’ve seen year-to-date, have left many fundamentally sound stocks trading at rock bottom prices. And that may have created an opportunity for investors willing do a bit of bottom fishing. The trick for investors, h
You don't need to gamble on a short squeeze to build your portfolio with these three blue-chip growth stocks.
Moderna's (NASDAQ: MRNA) stock is in poor shape. Unfortunately, when investors take a closer look at why Moderna's stock is so inexpensive, they probably won't want to make that purchase. The most obvious reason Moderna's stock is so cheap is that the market (and public) have moved beyond buying shares of heavily hyped vaccine stocks.
See who joins Meta and GOOGL on this screen of Warren Buffett stocks based on the investing strategy of Berkshire Hathaway's CEO.
Friday’s consumer-price index report for May — which showed the annual headline U.S. inflation rate climbing to 8.6% in May, with few signs of having peaked — is boosting the chances of a jumbo-sized rate increase by monetary-policy makers as soon as next week, and eliciting dire warnings that central bankers have completely lost control of prices. Fed funds futures traders now see a 21% chance of a 75-basis-point hike in June, up from just 3.6% on Thursday, according to the CME FedWatch Tool. Beneath the issue of where the Fed goes from here is a much more fundamental and serious problem: Some observers fear the U.S. central bank has already effectively lost control of inflation.
Inflation remains white-hot. These stocks can help stop the pain.
The bears have killed Carvana's share price this year, but don't be surprised if its stock gets back on the road to growth.
In this article, we discuss the 10 safe blue chip stocks to buy in June. If you want to skip our detailed analysis of the current market situation and blue chip stocks, go directly to 5 Safe Blue Chip Stocks to Buy in June. Inflation is eating away at the purchasing power of consumers across the […]
AMD painted a bright picture of its growing market opportunity, especially in data centers, at an analyst day presentation.
Markets are volatile. Use these dividend stocks for peace of mind.
Inflation has yet to peak and has only gotten worse since 2021, Tim Magnusson, chief investment officer of Garda Capital Partners, tells MarketWatch.
Real estate investment trusts (REITs) Innovative Industrial Properties (NYSE: IIPR) and Medical Properties Trust (NYSE: MPW) currently offer investors big-time dividends. Innovative Industrial Properties' payout yields 5.1%, while Medical Properties Trust's dividend is 6.7%. Both are well above the S&P 500's dividend yield (1.4%) and the REIT sector's 3% average.